Antibodies targeting a complex comprising non-classical HLA-I and neoantigen and their methods of use

Number of patents in Portfolio can not be more than 2000

United States of America

PATENT NO 11976120
APP PUB NO 20220033504A1
SERIAL NO

17199258

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Provided herein are antibodies that selectively bind to complex comprising a non-classical HLA-I (e.g. HLA-E) and a neoantigen having variable heavy chain domains (VH), variable light chain domains (VL), and complementarity determining regions (CDRs) as disclosed herein, as well as methods and uses thereof.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • BOEHRINGER INGELHEIM INTERNATIONAL GMBH

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Upchurch-Ange, Katherine Arlington, US 7 9
Weidanz, Jon Arlington, US 16 58

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 Nov 7, 2027
7.5 Year Payment $3600.00 $1800.00 $900.00 Nov 7, 2031
11.5 Year Payment $7400.00 $3700.00 $1850.00 Nov 7, 2035
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00